Stocks · Health care · Surgical & Medical Instruments & Apparatus

NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC Clue Score61
United States Fiscal year ends September CIK 0001500198 Results filed 5 Oct 2026

What the insiders did No buying or selling

By person

9 insiders · 0 transactions
4.0×

Dave Rosa holds only 4.0 times base salary in stock. $2.17M of shares against $535.43K in salary for 2025.

Salary from the company's own proxy. The shares are what Dave Rosa last reported holding, valued at $2.01, the price Common Stock was last bought or sold at on the open market here, on 27 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
David A Rosa
CEO & President
—
—
—
1,080,132
$2.17M
−5.2%
Ronald W. McClurg
Chief Financial Officer
—
—
—
444,117
$892.68K
+81.9%
David J. Wambeke
Chief Business Officer
—
—
—
199,999
$402.00K
—
Paul Buckman
Director
—
—
—
178,733
$359.25K
+63.9%
Jeffrey S Mathiesen
Director
—
—
—
156,343
$314.25K
+80.5%
Steve Mertens
Chief Technology Officer
—
—
—
152,141
$305.80K
−12.1%
Edward Andrle
Director
—
—
—
133,932
$269.20K
+108.5%
Jason Richard Mills
Director
—
—
—
49,687
$99.87K
—
Mark Christianson
Market Development Director
—
—
—
20,692
$41.59K
−83.6%

No percentages here. This company's share count has moved by a factor of 5.8 over the window, from 8,619,876 to 50,413,148 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.